Search

everythinglearnresearchcommunity

for

Search:↓

The Turkish version of the MAIA-2 Scale is valid and reliable for patients at a dermatology clinic.

Longer TA repeats in the SRD5A2 gene may increase acne risk in Chinese people.

Mini pulse corticosteroid therapy with oral dexamethasone is effective and has fewer side effects for treating extensive alopecia areata.

Allergic contact dermatitis may promote hair growth by activating hair follicle stem cells.

Certain groups of medications given when leaving the hospital are linked to a higher risk of negative drug reactions within 30 days, especially in older adults with respiratory issues.

A dissolving microneedle patch with dutasteride offers effective, long-lasting hair loss treatment with fewer side effects.

Teledermatology effectively diagnoses and manages non-scarring alopecia remotely.

DCPA is a chronic skin condition affecting the lower limbs, mainly in men, with unclear causes and treatments that often don't work well.

Tofacitinib may help treat severe hair loss, but more research is needed.

The Journal of Cutaneous and Aesthetic Surgery is now included in PubMed.

The SAAD-41 scale effectively measures the psychosocial impact of alopecia areata.

The TPAP method effectively categorizes androgenetic alopecia patients with high accuracy, but needs real-world validation.

The document showed detailed images of skin structures and discussed skin diseases and their diagnosis.

Early diagnosis and genetic counseling are crucial for managing adrenoleukodystrophy.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

Unable to summarize document.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Azelaic Acid is effective and safe for treating adult female acne, with few side effects.

Non-drug methods effectively managed agitation in a patient with a heart device, leading to improved mental function.

A new liposomal formulation improves drug delivery and hair growth for treating hair loss without causing skin irritation.

Oral baricitinib is effective and safe for treating alopecia areata.

Atopic dermatitis may trigger alopecia areata, and early treatment can help prevent severe cases.

Men with severe androgenetic alopecia, especially on the top of the head, have a higher risk of coronary artery disease.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

1′S-1′-Acetoxychavicol acetate may help treat hair loss by reducing oxidative stress.